SEARCH

SEARCH BY CITATION

References

  • 1
    CBS Sunday Morning ‘Caffeine Nation’, 7 September 2003. http://www.cbsnews.com
  • 2
    National Coffee Association Coffee Drinking Trends Survey 2000.
  • 3
    Specialty Coffee Association of America 1999 Market Report.
  • 4
    Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr 1999; 53: 8319.
  • 5
    Jec SH, He J, Appel LJ, et al. Coffee consumption and serum lipids; a meta-analysis of randomized controlled clinical trials. Am J Epidemol 2001; 153: 35362.
  • 6
    De Bree A, Verschuren WM, Blom HJ, Krombout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001; 154: 1504.
  • 7
    Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 1994; 72: 26975.
  • 8
    Myers MG, Basinski A. Coffee and coronary heart disease. Arch Intern Med 1992; 152: 176772.
  • 9
    Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004; 140: 18.
  • 10
    Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with risk of parkinsons disease. JAMA 2000; 283: 26749.
  • 11
    Arnesen E, Huseby NE, Brenn T, Try K. The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest 1986; 46: 6370.
  • 12
    Tanaka K, Tokunaga S, Kono S, et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998; 27: 43843.
  • 13
    Honjo S, Kono S, Coleman MP, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001; 54: 8239.
  • 14
    Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 2432.
  • 15
    Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006; 166: 11905.
  • 16
    Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992; 136: 124857.
  • 17
    Corrao G, Zambon A, Bagnardi V, D’Amicis A, Klatsky A, Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001; 11: 45865.
  • 18
    Gallus S, Tavani A, Negri E, La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002; 12: 2025.
  • 19
    Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003; 13: 41923.
  • 20
    La Vecchia C, Negri E, Cavalieri d’Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998; 7: 31520.
  • 21
    International Agency for Research on Cancer (IARC). Alcohol drinking. IARC Monogr Eval Carcinog Risks Hum 1988; 44: 2589.
  • 22
    International Agency for Research on Cancer (IARC). Hepatitis viruses. IARC Monogr Eval Carcinog Risks Hum 1994; 59: 255.
  • 23
    Gelatti U, Covolo L, Franceschini M, et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case–control study. J Hepatol 2005; 42: 52834.
  • 24
    Inoue M, Yoshimi I, Sobue T, Tsugane S, JPHC Study Group. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005; 97: 293300.
  • 25
    Pisani P, Parkin DN, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387400.
  • 26
    Kurozawa Y, Ogimoto I, Shibata A, et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005; 93: 60710.
  • 27
    Ohfuji S, Fukushima W, Tanaka T, et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chromic type C liver disease: a case–control study. Hepatol Res 2006; 36: 2018.
  • 28
    Tanaka K, Hara M, Sakamoto T, et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case–control study in Japan. Cancer Sci 2007; 98: 2148.
  • 29
    Montella M, Polesel J, La Vecchia C, et al. Coffee and tea consumption and the risk of hepatocellular carcinoma in Italy. Int J Cancer 2007; 120: 15559.
  • 30
    Wahllander A, Renner E, Preisig R. Fasting plasma caffeine concentration. A guide to the severity of chronic liver disease. Scand J Gastroenterol 1985; 20: 113341.
  • 31
    Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006; 46: 10123.
  • 32
    Sharp DS, Benowitz NL. Re: “Alcohol, smoking, coffee, and cirrhosis” and “coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan”. Am J Epidemiol 1995; 141: 4802.
  • 33
    Hosaka S, Kawa S, Aoki Y, et al. Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminoflluorene. Food Chem Toxicol 2001; 39: 55761.
  • 34
    Tanaka T, Nishikawa A, Shima H, et al. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 1990; 52: 42940.
  • 35
    Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Shilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002; 40: 115563.
  • 36
    Huber WW, Prustomersky S, Delbanco E, et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by coffee components kahweol and cafestol. Arch Toxicol 2002; 76: 20917.
  • 37
    Huber WW, Scharf G, Rossmanith W, et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 2002; 75: 68594.
  • 38
    Urgert R, Shulz AGM, Katan MB. Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans. Am J Clin Nutr 1995; 61: 14954.
  • 39
    Weusten-Van der Woum MPME, Katan MB, Viani R, et al. Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function. J Lipid Res 1994; 35: 72133.
  • 40
    McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. Anal Toxicol 2003; 27: 5202.